BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Amarantus BioSciences, Inc.  

675 Almanor Avenue

Sunnyvale  California  94085  U.S.A.
Phone: 408-737-2734 Fax: 408-852-4427


SEARCH JOBS




Industry
Biotechnology






 Company News
Amarantus BioSciences, Inc. Appoints Iain Ross To Board Of Directors 8/29/2014 8:47:12 AM
Amarantus BioSciences, Inc. Reports Second Quarter 2014 Financial Results, Announces Business Update Call 8/27/2014 7:55:04 AM
Amarantus BioSciences, Inc. To Present At Upcoming Investor Conferences 8/19/2014 7:26:41 AM
Amarantus BioSciences, Inc. Enters Into Research Collaboration With The Buck Institute for Age Research For MANF 8/11/2014 7:39:59 AM
Amarantus BioSciences, Inc. Release: #C4CT Summit Explored Emerging Theories On Traumatic Brain Injury, Chronic Traumatic Encephalopathy And Possible Links To Alzheimer's 8/4/2014 8:15:03 AM
Amarantus BioSciences, Inc. Announces Positive Top-Line Interim Clinical Data For Alzheimer's Blood Diagnostic Lympro Test® 8/4/2014 7:46:21 AM
Amarantus BioSciences, Inc. Acquires Exclusive Option To License Alzheimer's Therapeutic IP Of Dr. Thomas Arendt From University of Leipzig 8/1/2014 8:30:19 AM
Amarantus BioSciences, Inc. Amends LymPro LP-002 Clinical Protocol to Report Interim Data at Presentation 7/30/2014 10:37:53 AM
Amarantus BioSciences, Inc. Appoints Donald D. Huffman To Board Of Directors 7/28/2014 8:49:06 AM
Amarantus BioSciences, Inc. And BSI Announce Dr. Thomas Arendt As Presenter At 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit At United Nations 7/24/2014 8:53:00 AM
12345678910...